The University of Tübingen, officially the Eberhard Karl University of Tübingen, is a public research university located in the city of Tübingen, Baden-Württemberg, Germany. The University of Tübingen is one of eleven German Excellence Universities.

During the past decade, University of Tubingen conducted 35 clinical trials. In the 10-year time frame, 35 clinical trials started and 21 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 11 clinical trials were completed. i.e. 84.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Tubingen" #1 sponsor was "University Hospital Tuebingen" with 15 trials, followed by "European Organisation for Research and Treatment of Cancer - EORTC" with 9 trials sponsored, "Bayer" with 7 trials sponsored, "Fred Hutchinson Cancer Center" with 4 trials sponsored and "Celgene" with 4 trials sponsored. Other sponsors include 39 different institutions and companies that sponsored additional 39 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Tubingen" #1 collaborator was "National Cancer Institute (NCI)" with 4 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 3 trials as a collaborator, "Foundation Fighting Blindness" with 2 trials as a collaborator, "Foundation Medicine" with 2 trials as a collaborator and "Institute for Neurodegenerative Disorders" with 2 trials as a collaborator. Other collaborators include 50 different institutions and companies that were collaborators in the rest 57 trials.

According to Clinical.Site data, the most researched conditions in "University of Tubingen" are "Acute Myeloid Leukemia" (4 trials), "Refractory Chronic Lymphocytic Leukemia" (4 trials), "Colorectal Cancer" (3 trials), "Leukemia" (3 trials) and "Mantle Cell Lymphoma" (3 trials). Many other conditions were trialed in "University of Tubingen" in a lesser frequency.

Most popular intervention types in "University of Tubingen" are "Drug" (53 trials), "Procedure" (15 trials), "Device" (9 trials), "Radiation" (9 trials) and "Other" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Fludarabine Phosphate" (3 trials), "Mycophenolate Mofetil" (3 trials), "Peripheral Blood Stem Cell Transplantation" (3 trials) and "Total-Body Irradiation" (3 trials). Other intervention names were less common.

The vast majority of trials in "University of Tubingen" are 78 trials for "All" genders, 3 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "University of Tubingen". undefined are not yet recruiting, 8 are recruiting, 8 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 46 completed trials in University of Tubingen, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in University of Tubingen, 5 "Phase 1" clinical trials were conducted, 22 "Phase 2" clinical trials and 34 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 16 trials that are defined as “Not Applicable".

University of Tubingen has several departments that took part in Clinical trials: "Universitätsklinikum Tübingen; Klinik für Urologie" - 18 trials, "University Hospital Tuebingen, Department of Women's Health" - 16 trials, "University of Tuebingen, Department of Internal Medicine IV" - 3 trials, "Universitätsklinik Tübingen; Psychiatrie und Psychotherapie" - 14 trials, "Universitätsklinikum Tübingen Medizinische UNI-Klinik und Poliklinik Abt. Innere Medizin II" - 14 trials, "Universitätsklinikum Tübingen, Zentrum für Neurologie" - 10 trials, "University children´s hospital" - 10 trials, "University Hospital Tuebingen, Department of Orthopaedics" - 8 trials, "Klinikum der Eberhard-Karls-Universität/Abt. für innere Med. II/Hämatologie/Onkologie-Germany" - 6 trials, "Skin Cancer Program, Department of Dermatology, Liebermeisterstrasse 8" - 5 trials, "University Hospital Tübingen, Department of Radiation Oncology" - 5 trials, "South West German Cancer Center, University of Tuebingen Medical Center" - 5 trials, "University of Tübingen, Department of Psychiatry and Psychotherapy" - 4 trials, "Universität Tübingen; Med. Klinik; Innere Medizin I" - 3 trials, "Universitätsklinikum Tübingen, Department of Radiation Therapy and Radiation Oncology" - 2 trials, "Universitätsklinik Tübingen Klinik für Kinderheilkunde und Jugendmedizin, Päd. Hämatologie / Onkologie" - 2 trials, "Institute of Medical Microbiology and Hygiene, University Hospital of Tuebingen" - 2 trials, "Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy" - 2 trials, "University of Tuebingen, Internal medicine IV" - 2 trials, "Universitätsklinikum Tübingen; Innere Medizin VIII, Medizinische Onkologie und Pneumologie" - 2 trials, "Universitätsklinikum Tübingen, Klinik für Anästhesiologie und Intensivmedizin" - 2 trials, "Prof. Dr. A. Batra/ Dr. Kristina Fuhr, University Department for Psychiatry and Psychotherapie" - 2 trials